Mariarosaria Miloso

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Protein Protein

Multiple Myeloma

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alessio Malacrida, Marie Deschamps-Wright, Roberta Rigolio, Guido Cavaletti, Mariarosaria Miloso
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. International journal of molecular sciences 24 (2) (2023)
Alessio Malacrida, Marie Deschamps-Wright, Roberta Rigolio, Guido Cavaletti, Mariarosaria Miloso
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. International journal of molecular sciences 24 (2) (2023)
Alessio Malacrida, Marie Deschamps-Wright, Roberta Rigolio, Guido Cavaletti, Mariarosaria Miloso
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. International journal of molecular sciences 24 (2) (2023)
Alessio Malacrida, Marie Deschamps-Wright, Roberta Rigolio, Guido Cavaletti, Mariarosaria Miloso
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. International journal of molecular sciences 24 (2) (2023)
Roberta Listro, Alessio Malacrida, Francesca Alessandra Ambrosio, Giacomo Rossino, Marcello Di Giacomo, Valeria Cavalloro, Martina Garbagnoli, Pasquale Linciano, Daniela Rossi, Guido Cavaletti, Giosuè Costa, Stefano Alcaro, Mariarosaria Miloso, Simona Collina
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells. International journal of molecular sciences 23 (21) (2022)
Alessio Malacrida, Guido Cavaletti, Mariarosaria Miloso
Rigosertib and Cholangiocarcinoma: A Cell Cycle Affair. International journal of molecular sciences 23 (1) (2021)
Alessio Malacrida, Valeria Cavalloro, Emanuela Martino, Giosuè Costa, Francesca Alessandra Ambrosio, Stefano Alcaro, Roberta Rigolio, Arianna Cassetti, Mariarosaria Miloso, Simona Collina
Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa-Part 2. Molecules (Basel, Switzerland) 26 (21) (2021)